GHRS
GHRS
NASDAQ · Pharmaceuticals

Gh Research Plc

$21.08
+0.07 (+0.33%)
As of May 9, 1:40 AM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +128.8% upside
Low Target $34.28
Average Target $48.23
High Target $66.93
Current Price $21.08
Current
$21.08
Target
$48.23
$34.28 $48.23 avg $66.93
Scenario Analysis
Bear Case
$34.28
62.6%
Low target
Base Case
$48.23
+128.8%
Avg target
Bull Case
$66.93
+217.5%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$24.66
-14.5% from high
52-Week Low
$9.46
+122.9% from low
Target vs 52W High
$48.23
+95.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%